Nitrosative stress inhibits production of the virulence factor alginate in mucoid Pseudomonas aeruginosa

References

• Deretic V. Pseudomonas aeruginosa infections. Persistant bacterial infections, JP Nataro, MJ Blaser, S Cunningham-Runddles. ASM Press, Washington, DC 2000; 305–326
   Google Scholar
• Goldberg JB, Pier GB. The role of the CFTR in susceptibility to Pseudomonas aeruginosa infections in cystic fibrosis. Trends Microbiol 2000; 8: 514–520
   PubMed Web of Science ®Google Scholar
• FitzSimmons SC. The changing epidemiology of cystic fibrosis. J Pediatr 1993; 122: 1–9
   PubMed Web of Science ®Google Scholar
• Koch C, Hoiby N. Pathogenesis of cystic fibrosis. Lancet 1993; 341: 1065–1069
   PubMed Web of Science ®Google Scholar
• Koch C, Hoiby N. Diagnosis and treatment of cystic fibrosis. Respiration 2000; 67: 239–247
   PubMedGoogle Scholar
• Govan JRW, Deretic V. Microbial pathogenesis in cystic fibrosis: Mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 1996; 60: 539–574
   PubMedGoogle Scholar
• Martin DW, et al. Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients. Proc Natl Acad Sci USA 1993; 90: 8377–8381
   PubMed Web of Science ®Google Scholar
• Fyfe JA, Govan JR. Alginate synthesis in mucoid Pseudomonas aeruginosa: A chromosomal locus involved in control. J Gen Microbiol 1980; 119: 443–450
   PubMedGoogle Scholar
• McAvoy MJ, et al. Isolation of mucoid strains of Pseudomonas aeruginosa from non-cystic- fibrosis patients and characterisation of the structure of their secreted alginate. J Med Microbiol 1989; 28: 183–189
   PubMedGoogle Scholar
• Ramsey DM, Wozniak DJ. Understanding the control of Pseudomonas aeruginosa alginate synthesis and the prospects for management of chronic infections in cystic fibrosis. Mol Microbiol 2005; 56: 309–322
   PubMed Web of Science ®Google Scholar
• Pedersen SS, et al. Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis. Thorax 1992; 47: 6–13
   PubMed Web of Science ®Google Scholar
• Pedersen SS. Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis. APMIS 1992; 100(Suppl. 28)1–79
   PubMedGoogle Scholar
• Firoved AM, Ornatowski W, Deretic V. Microarray analysis reveals induction of lipoprotein genes in mucoid Pseudomonas aeruginosa: Implications for inflammation in cystic fibrosis. Infect Immun 2004; 72: 5012–5018
   PubMed Web of Science ®Google Scholar
• Koch C. Early infection and progression of cystic fibrosis lung disease. Pediatr Pulmonol 2002; 34: 232–236
   PubMed Web of Science ®Google Scholar
• Bonfield TL, et al. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med 1995; 152: 2111–2118
   PubMed Web of Science ®Google Scholar
• Cobb LM, et al. Pseudomonas aeruginosa flagellin and alginate elicit very distinct gene expression patterns in airway epithelial cells: Implications for cystic fibrosis disease. J Immunol 2004; 173: 5659–5670
   PubMed Web of Science ®Google Scholar
• Bagge N, et al. Pseudomonas aeruginosa biofilms exposed to imipenem exhibit changes in global gene expression and beta-lactamase and alginate production. Antimicrob Agents Chemother 2004; 48: 1175–1187
   PubMed Web of Science ®Google Scholar
• Boucher JC, et al. Mucoid Pseudomonas aeruginosa in cystic fibrosis: Characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection. Infect Immun 1997; 65: 3838–3846
   PubMedGoogle Scholar
• Deretic V, et al. Conversion of Pseudomonas aeruginosa to mucoidy in cystic fibrosis: Environmental stress and regulation of bacterial virulence by alternative sigma factors. J Bacteriol 1994; 176: 2773–2780
   PubMed Web of Science ®Google Scholar
• Firoved AM, Deretic V. Microarray analysis of global gene expression in mucoid Pseudomonas aeruginosa. J Bacteriol 2003; 185: 1071–1081
   PubMed Web of Science ®Google Scholar
• DeVries CA, Ohman DE. Mucoid-to-nonmucoid conversion in alginate-producing Pseudomonas aeruginosa often results from spontaneous mutations in algT, encoding a putative alternate sigma factor, and shows evidence for autoregulation. J Bacteriol 1994; 176: 6677–6687
   PubMed Web of Science ®Google Scholar
• Schurr MJ, et al. Gene cluster controlling conversion to alginate-overproducing phenotype in Pseudomonas aeruginosa: Functional analysis in a heterologous host and role in the instability of mucoidy. J Bacteriol 1994; 176: 3375–3382
   PubMedGoogle Scholar
• Pier GB, et al. Role of alginate O acetylation in resistance of mucoid Pseudomonas aeruginosa to opsonic phagocytosis. Infect Immun 2001; 69: 1895–1901
   PubMed Web of Science ®Google Scholar
• Oliver AM, Weir DM. The effect of Pseudomonas alginate on rat alveolar macrophage phagocytosis and bacterial opsonization. Clin Exp Immunol 1985; 59: 190–196
   PubMedGoogle Scholar
• Oliver AM, Weir DM. Inhibition of bacterial binding to mouse macrophages by Pseudomonas alginate. J Clin Lab Immunol 1983; 10: 221–224
   PubMedGoogle Scholar
• Simpson JA, Smith SE, Dean RT. Alginate inhibition of the uptake of Pseudomonas aeruginosa by macrophages. J Gen Microbiol 1988; 134: 29–36
   PubMedGoogle Scholar
• Franklin MJ, Ohman DE. Mutant analysis and cellular localization of the AlgI, AlgJ, and AlgF proteins required for O acetylation of alginate in Pseudomonas aeruginosa. J Bacteriol 2002; 184: 3000–3007
   PubMedGoogle Scholar
• Chan C, Burrows LL, Deber CM. Alginate as an auxiliary bacterial membrane: Binding of membrane-active peptides by polysaccharides. J Pept Res 2005; 65: 343–351
   PubMedGoogle Scholar
• Yoon SS, et al. Pseudomonas aeruginosa anaerobic respiration in biofilms: Relationships to cystic fibrosis pathogenesis. Dev Cell 2002; 3: 593–603
   PubMed Web of Science ®Google Scholar
• Hassett DJ. Anaerobic production of alginate by Pseudomonas aeruginosa: Alginate restricts diffusion of oxygen. J Bacteriol 1996; 178: 7322–7325
   PubMed Web of Science ®Google Scholar
• Nichols WW, et al. Inhibition of tobramycin diffusion by binding to alginate. Antimicrob Agents Chemother 1988; 32: 518–523
   PubMed Web of Science ®Google Scholar
• Learn DB, Brestel EP, Seetharama S. Hypochlorite scavenging by Pseudomonas aeruginosa alginate. Infect Immun 1987; 55: 1813–1818
   PubMed Web of Science ®Google Scholar
• Wong TY, Preston LA, Schiller NL. Alginate lyase: Review of major sources and enzyme characteristics, structure–function analysis, biological roles, and applications. Annu Rev Microbiol 2000; 54: 289–340
   PubMed Web of Science ®Google Scholar
• Hatch RA, Schiller NL. Alginate lyase promotes diffusion of aminoglycosides through the extracellular polysaccharide of mucoid Pseudomonas aeruginosa. Antimicrob Agents Chemother 1998; 42: 974–977
   PubMed Web of Science ®Google Scholar
• Mrsny RJ, et al. Addition of a bacterial alginate lyase to purulent CF sputum in vitro can result in the disruption of alginate and modification of sputum viscoelasticity. Pulm Pharmacol 1994; 7: 357–366
   PubMedGoogle Scholar
• Pier GB, et al. Human monoclonal antibodies to Pseudomonas aeruginosa alginate that protect against infection by both mucoid and nonmucoid strains. J Immunol 2004; 173: 5671–5678
   PubMed Web of Science ®Google Scholar
• Kelley TJ, Drumm ML. Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells. J Clin Invest 1998; 102: 1200–1207
   PubMed Web of Science ®Google Scholar
• Snyder AH, et al. Acute effects of aerosolized S-nitrosoglutathione in cystic fibrosis. Am J Respir Crit Care Med 2002; 165: 922–926
   PubMed Web of Science ®Google Scholar
• Grasemann H, et al. Decreased levels of nitrosothiols in the lower airways of patients with cystic fibrosis and normal pulmonary function. J Pediatr 1999; 135: 770–772
   PubMed Web of Science ®Google Scholar
• Hess DT, et al. Protein S-nitrosylation: Purview and parameters. Nat Rev Mol Cell Biol 2005; 6: 150–166
   PubMed Web of Science ®Google Scholar
• Gaston B, et al. Nitrogen redox balance in the cystic fibrosis airway: Effects of antipseudomonal therapy. Am J Respir Crit Care Med 2002; 165: 387–390
   PubMedGoogle Scholar
• Firoved AM, et al. Microarray analysis and functional characterization of the nitrosative stress response in nonmucoid and mucoid Pseudomonas aeruginosa. J Bacteriol 2004; 186: 4046–4050
   Google Scholar
• Nussler AK, Billiar TR. Inflammation, immunoregulation, and inducible nitric oxide synthase. J Leukoc Biol 1993; 54: 171–178
   PubMed Web of Science ®Google Scholar
• Singh PK, et al. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 2000; 407: 762–764
   PubMed Web of Science ®Google Scholar
• Hoffman LR, et al. Aminoglycoside antibiotics induce bacterial biofilm formation. Nature 2005; 436: 1171–1175
   PubMed Web of Science ®Google Scholar
• Grasemann H, et al. Endothelial nitric oxide synthase variants in cystic fibrosis lung disease. Am J Respir Crit Care Med 2003; 167: 390–394
   PubMedGoogle Scholar
• Zeitlin PL, et al. A cystic fibrosis bronchial epithelial cell line: Immortalization by adeno-12-SV40 infection. Am J Respir Crit Care Med 1991; 4: 313–319
   Google Scholar
• Egan M, et al. Defective regulation of outwardly rectifying Cl-channels by protein kinase A corrected by insertion of CFTR [see comments]. Nature 1992; 358: 581–584
   PubMed Web of Science ®Google Scholar
• Darling K, Evans T. Effects of nitric oxide on Pseudomonas aeruginosa infection of epithelial cells from a human respiratory cell line derived from a patient with cystic fibrosis. Infect Immun 2003; 71: 2341–2349
   PubMed Web of Science ®Google Scholar
• Fratti RA, et al. Role of phosphatidylinositol 3-kinase and Rab5 effectors in phagosomal biogenesis and mycobacterial phagosome maturation arrest. J Cell Biol 2001; 154: 631–644
   PubMed Web of Science ®Google Scholar
• Hart TW. Some observations concerning the s-nitroso and s-phenylsulfonyl derivatives of l-cysteine and glutathione. Tetrahedron Lett 1985; 26: 2013–2016
   Web of Science ®Google Scholar
• Martin DW, et al. Differentiation of Pseudomonas aeruginosa into the alginate-producing form: Inactivation of mucB causes conversion to mucoidy. Mol Microbiol 1993; 9: 497–506
   PubMedGoogle Scholar
• Elphick HE, et al. Exhaled nitric oxide is reduced in infants with cystic fibrosis. Thorax 2001; 56: 151–152
   PubMedGoogle Scholar
• Thomas SR, et al. Nasal and exhaled nitric oxide is reduced in adult patients with cystic fibrosis and does not correlate with cystic fibrosis genotype. Chest 2000; 117: 1085–1089
   PubMed Web of Science ®Google Scholar
• Perkett EA, et al. Chloroquine normalizes aberrant transforming growth factor beta activity in cystic fibrosis bronchial epithelial cells. Pediatr Pulmonol 2006; 41: 771–778
   PubMedGoogle Scholar
• Poschet JF, et al. Molecular basis for defective glycosylation and Pseudomonas pathogenesis in cystic fibrosis lung. Proc Natl Acad Sci USA 2001; 98: 13972–13977
   PubMedGoogle Scholar
• Poschet JF, et al. Endosomal hyperacidification in cystic fibrosis is due to defective nitric oxide-cylic GMP signalling cascade. EMBO Rep 2006; 7: 553–559
   PubMed Web of Science ®Google Scholar
• Poschet JF, et al. Hyperacidification of cellubrevin endocytic compartments and defective endosomal recycling in cystic fibrosis respiratory epithelial cells. J Biol Chem 2002; 277: 13959–13965
   PubMedGoogle Scholar
• Wozniak DJ, et al. Alginate is not a significant component of the extracellular polysaccharide matrix of PA14 and PAO1 Pseudomonas aeruginosa biofilms. Proc Natl Acad Sci USA 2003; 100: 7907–7912
   PubMed Web of Science ®Google Scholar
• Bragonzi A, et al. Nonmucoid Pseudomonas aeruginosa expresses alginate in the lungs of patients with cystic fibrosis and in a mouse model. J Infect Dis 2005; 192: 410–419
   PubMed Web of Science ®Google Scholar
• Deretic V, Gill JF, Chakrabarty AM. Gene algD coding for GDPmannose dehydrogenase is transcriptionally activated in mucoid Pseudomonas aeruginosa. J Bacteriol 1987; 169: 351–358
   PubMedGoogle Scholar
• Chu L, et al. Nucleotide sequence and expression of the algE gene involved in alginate biosynthesis by Pseudomonas aeruginosa. Gene 1991; 107: 1–10
   PubMed Web of Science ®Google Scholar
• Rehm BH, et al. Overexpression of algE in Escherichia coli: Subcellular localization, purification, and ion channel properties. J Bacteriol 1994; 176: 5639–5647
   PubMed Web of Science ®Google Scholar
• Flatley J, et al. Transcriptional responses of Escherichia coli to S-nitrosoglutathione under defined chemostat conditions reveal major changes in methionine biosynthesis. J Biol Chem 2005; 280: 10065–10072
   PubMedGoogle Scholar
• Bayer AS, et al. Effects of alginase on the natural history and antibiotic therapy of experimental endocarditis caused by mucoid Pseudomonas aeruginosa. Infect Immun 1992; 60: 3979–3985
   PubMed Web of Science ®Google Scholar
• Fuchs HJ, et al. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. N Engl J Medicine 1994; 331: 637–642, The Pulmozyme Study Group.
   PubMed Web of Science ®Google Scholar
• Shak S, et al. Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum. Proc Natl Acad Sci USA 1990; 87: 9188–9192
   PubMed Web of Science ®Google Scholar